Penbrook Management’s VivoSim Labs VIVS Stock Holding History

Penbrook Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,099	Closed	-$138K	–	106
2019 Q2	$138K	Sell	1,099 -41	-4%	-$7.75K	0.15%	97
2019 Q1	$272K	Hold	1,140	–	–	0.28%	88
2018 Q4	$262K	Buy	1,140 +16	+1%	+$4.03K	0.3%	88
2018 Q3	$310K	Hold	1,124	–	–	0.3%	85
2018 Q2	$377K	Hold	1,124	–	–	0.36%	80
2018 Q1	$278K	Hold	1,124	–	–	0.28%	86
2017 Q4	$361K	Buy	+1,124	New	+$418K	0.33%	80
2016 Q3	$1.05M	Buy	1,150 +40	+4%	+$39.2K	1.13%	31
2016 Q2	$992K	Buy	1,110 +292	+36%	+$196K	1.09%	31
2016 Q1	$426K	Buy	818 +103	+14%	+$52.4K	0.47%	70
2015 Q4	$427K	Sell	715 -9	-1%	-$6.53K	0.44%	80
2015 Q3	$465K	Sell	724 -3	-0.4%	-$2.28K	0.49%	72
2015 Q2	$658K	Buy	727 +213	+41%	+$238K	0.62%	63
2015 Q1	$436K	Sell	514 -2	-0.4%	-$2.76K	0.39%	85
2014 Q4	$898K	Hold	516	–	–	0.81%	48
2014 Q3	$789K	Sell	516 -3	-0.6%	-$5.44K	0.73%	57
2014 Q2	$1.04M	Buy	519 +19	+4%	+$31.8K	0.92%	43
2014 Q1	$916K	Hold	500	–	–	0.87%	46
2013 Q4	$1.33M	Buy	+500	New	+$981K	1.29%	25

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Penbrook Management's VIVS Position: Q3 2019 in Review

Penbrook Management sold out of VivoSim Labs (VIVS) in Q3 2019, closing a stake of 1,099 shares — an estimated $138K sold.

Penbrook Management first reported a position in VIVS in Q4 2013 and held it in 19 quarters. The position peaked at $1.33M in Q4 2013. 78 funds tracked by Wall St. Rank hold VIVS as of Q3 2019.

Penbrook Management reported no remaining VivoSim Labs position as of Q3 2019 after selling out during the quarter.
Penbrook Management sold 1,099 VivoSim Labs shares in Q3 2019, an estimated $138K.
Penbrook Management first reported a position in VivoSim Labs in Q4 2013 and held it in 19 quarters.
Penbrook Management's VivoSim Labs position peaked at $1.33M in Q4 2013.
78 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2019.

Based on Penbrook Management's 13F filing for Q3 2019, filed 11 Oct 2019.